International Centre for Evidence in Disability, Department of Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
International Centre for Evidence in Disability, Department of Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK; Division of Physiotherapy, Department of Health and Rehabilitation Sciences, Stellenbosch University, Cape Town, South Africa.
Public Health. 2023 Sep;222:115-124. doi: 10.1016/j.puhe.2023.06.032. Epub 2023 Jun 29.
To undertake a systematic review and meta-analysis to estimate the relative risk of COVID-19-related mortality among people with disabilities compared to people without disabilities.
Systematic review and meta-analysis.
We systematically searched four databases from March 1, 2020, to August 15, 2022. We included prospective studies with a baseline assessment of disability and a longitudinal assessment of the COVID-19-related mortality. Two reviewers independently assessed study eligibility, extracted data, and assessed risk of bias. We undertook random-effects meta-analyses to calculate pooled adjusted hazard ratios for COVID-19-related mortality for people with disabilities, also disaggregated by disability type and study setting.
We identified 2596 articles throughout the electronic data search, and 56 studies were included in the review. Most (73%) had a moderate risk of bias. The pooled adjusted effect estimate for COVID-19-related mortality in people with disabilities compared to those without was 2.7 (95% confidence interval [CI]: 2.4-3.2). Heterogeneity between the studies was high (τ = 0.28, I = 97%). Effect estimates were highest for population-based samples (3.3, 95% CI: 2.7-3.9), compared to hospital settings (2.1, 95% CI: 1.7-2.7). Risk was not elevated among people with disabilities in care home settings (1.6, 95% CI: 0.7-3.5). Disaggregation by disability type showed that people with intellectual disabilities were at the highest relative risk of COVID-19 mortality.
Risk of COVID-19 mortality is elevated among people with disabilities, especially people with intellectual disabilities. Efforts are needed to collect better routine data on disability and to include people with disabilities in the pandemic response for COVID-19.
系统回顾和荟萃分析,以估计残疾人群与非残疾人群 COVID-19 相关死亡率的相对风险。
系统回顾和荟萃分析。
我们系统地检索了四个数据库,检索时间从 2020 年 3 月 1 日至 2022 年 8 月 15 日。我们纳入了在基线评估残疾状况和纵向评估 COVID-19 相关死亡率方面具有前瞻性的研究。两名评审员独立评估研究的纳入标准、提取数据并评估偏倚风险。我们进行了随机效应荟萃分析,以计算残疾人群 COVID-19 相关死亡率的汇总调整后的危险比,并按残疾类型和研究场所进行了细分。
我们在电子数据检索中总共确定了 2596 篇文章,其中 56 项研究纳入了综述。大多数(73%)研究的偏倚风险为中度。与非残疾人群相比,残疾人群 COVID-19 相关死亡率的汇总调整后的效应估计值为 2.7(95%置信区间[CI]:2.4-3.2)。研究之间的异质性很高(τ=0.28,I=97%)。与医院环境相比,基于人群的样本的效应估计值最高(3.3,95%CI:2.7-3.9),而医院环境的效应估计值较低(2.1,95%CI:1.7-2.7)。在养老院环境中,残疾人群的风险并未升高(1.6,95%CI:0.7-3.5)。按残疾类型细分显示,智力残疾人群 COVID-19 死亡率的相对风险最高。
残疾人群 COVID-19 死亡率较高,尤其是智力残疾人群。需要努力收集关于残疾的更好的常规数据,并将残疾人群纳入 COVID-19 大流行的应对工作中。